My preference also, licence out Nz-2591 similar to Acadia US deal, perhaps better terms and nice upfront!
This would again have our partner do the heavy lifting, Neu just collect royalty/milestone revenue from all.
10-15% from all sales from our pipeline would generate plenty of revenue for Neu based on recent Trof peak sales estimate and royalties, certainly give us share price $100-$150+
This is a win for all holders and management, least work, enjoy the ride and collect the cash/divi’s
This is exactly why should a TO be even considered it needs to be premium in my view!
- Forums
- ASX - By Stock
- Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference
My preference also, licence out Nz-2591 similar to Acadia US...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.61 |
Change
0.140(1.12%) |
Mkt cap ! $1.611B |
Open | High | Low | Value | Volume |
$12.45 | $12.62 | $12.22 | $2.973M | 237.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1257 | $12.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.62 | 1257 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1257 | 12.520 |
4 | 5178 | 12.510 |
3 | 1572 | 12.500 |
2 | 1634 | 12.490 |
1 | 2000 | 12.410 |
Price($) | Vol. | No. |
---|---|---|
12.620 | 1257 | 1 |
12.630 | 39 | 2 |
12.640 | 1257 | 1 |
12.680 | 400 | 1 |
12.750 | 1000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |